Index RUT
P/E -
EPS (ttm) -1.01
Insider Own 5.11%
Shs Outstand 39.68M
Perf Week 1.37%
Market Cap 2.00B
Forward P/E -
EPS next Y -0.53
Insider Trans -6.60%
Shs Float 37.66M
Perf Month -2.46%
Income -36.77M
PEG -
EPS next Q -0.23
Inst Own 82.59%
Short Float 5.99%
Perf Quarter 5.13%
Sales 115.18M
P/S 17.33
EPS this Y 42.04%
Inst Trans -0.37%
Short Ratio 4.67
Perf Half Y -8.43%
Book/sh 6.95
P/B 7.24
EPS next Y 35.67%
ROA -14.69%
Short Interest 2.26M
Perf Year 104.10%
Cash/sh 5.88
P/C 8.55
EPS next 5Y -
ROE -17.01%
52W Range 20.66 - 66.54
Perf YTD 24.73%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -12.86%
52W High -24.42%
Beta 1.19
Dividend TTM -
Quick Ratio 13.34
Sales past 5Y 201.89%
Gross Margin 66.26%
52W Low 143.42%
ATR (14) 1.70
Dividend Ex-Date -
Current Ratio 14.33
EPS Y/Y TTM 49.16%
Oper. Margin -36.78%
RSI (14) 49.28
Volatility 2.67% 3.42%
Employees 374
Debt/Eq 0.04
Sales Y/Y TTM 71.90%
Profit Margin -31.93%
Recom 1.00
Target Price 64.50
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 60.48%
Payout -
Rel Volume 0.48
Prev Close 50.52
Sales Surprise 7.92%
EPS Surprise 28.22%
Sales Q/Q 67.65%
Earnings Aug 05 AMC
Avg Volume 483.25K
Price 50.29
SMA20 2.01%
SMA50 -3.23%
SMA200 -4.38%
Trades
Volume 231,847
Change -0.46%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-20-24 Reiterated
Needham
Buy
$54 → $66
Aug-06-24 Reiterated
Needham
Buy
$75 → $54
May-07-24 Reiterated
BTIG Research
Buy
$61 → $72
Dec-13-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$31 → $42
Dec-12-23 Initiated
Stifel
Buy
$40
Dec-04-23 Initiated
Morgan Stanley
Overweight
$36
Apr-13-23 Initiated
Oppenheimer
Outperform
$23
Dec-12-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$20 → $14
Apr-08-22 Initiated
Needham
Buy
$18
Oct-15-24 06:10PM
Oct-13-24 05:33PM
Aug-22-24 04:05PM
Aug-19-24 03:43PM
(Investor's Business Daily)
Aug-12-24 09:55AM
09:55AM
Loading…
Aug-06-24 09:55AM
(Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM
04:05PM
11:20AM
Jul-29-24 09:35AM
Jul-22-24 04:05PM
Jul-12-24 09:35AM
Jul-10-24 10:59AM
(Investor's Business Daily) -10.32%
Jun-18-24 01:50AM
Jun-13-24 11:22AM
(Investor's Business Daily)
02:40PM
Loading…
Jun-07-24 02:40PM
(Investor's Business Daily)
Jun-05-24 04:05PM
May-30-24 04:00AM
May-28-24 12:00PM
May-24-24 11:40AM
(Investor's Business Daily)
May-13-24 04:58PM
04:05PM
May-08-24 09:15PM
04:05PM
May-07-24 12:17PM
08:50AM
08:49AM
08:48AM
08:28AM
06:42AM
(Thomson Reuters StreetEvents)
04:26AM
Loading…
04:26AM
03:10AM
May-06-24 05:37PM
05:06PM
04:05PM
May-02-24 05:03PM
May-01-24 04:05PM
Apr-22-24 04:05PM
Apr-04-24 04:05PM
Mar-27-24 04:05PM
Feb-29-24 07:05PM
11:09AM
08:36AM
(Thomson Reuters StreetEvents)
Feb-28-24 04:38PM
04:05PM
Feb-14-24 04:05PM
Jan-19-24 05:01PM
Jan-12-24 03:16PM
Jan-09-24 06:19PM
Jan-07-24 10:00AM
Dec-27-23 04:05PM
Nov-15-23 09:30AM
Nov-12-23 10:26AM
Nov-10-23 07:42AM
(Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM
Nov-02-23 09:00AM
Oct-26-23 04:05PM
Sep-07-23 09:35AM
Aug-23-23 04:05PM
Aug-22-23 05:20PM
Aug-18-23 09:23AM
Aug-17-23 08:37AM
Aug-08-23 08:44AM
06:21AM
(Thomson Reuters StreetEvents)
Aug-07-23 06:15PM
04:05PM
Jul-25-23 04:05PM
Jun-30-23 08:31AM
Jun-27-23 08:38AM
Jun-18-23 10:53AM
May-10-23 07:52AM
(Thomson Reuters StreetEvents) +9.87%
May-09-23 06:15PM
04:05PM
May-03-23 10:00AM
May-02-23 10:02AM
Apr-26-23 06:33PM
04:05PM
Apr-25-23 04:05PM
Apr-24-23 04:05PM
Apr-18-23 11:26AM
Apr-11-23 12:00PM
Apr-05-23 04:05PM
Mar-13-23 09:55AM
Mar-08-23 07:21AM
Mar-07-23 08:23AM
(Thomson Reuters StreetEvents)
05:16AM
Mar-06-23 04:05PM
Feb-28-23 04:05PM
Feb-21-23 04:05PM
Feb-14-23 04:05PM
Feb-08-23 12:45AM
Feb-07-23 04:05PM
Jan-09-23 08:56AM
Jan-08-23 04:00PM
Dec-31-22 06:15AM
Dec-28-22 04:05PM
Dec-22-22 09:40AM
Dec-06-22 09:40AM
Dec-02-22 09:55AM
Nov-16-22 09:55AM
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Goldshleger Ilya See remarks Oct 22 '24 Option Exercise 15.08 3,100 46,748 45,346 Oct 22 08:17 PM Goldshleger Ilya See remarks Oct 22 '24 Sale 49.68 3,100 154,001 42,246 Oct 22 08:17 PM ILYA GOLDSHLEGER Officer Oct 22 '24 Proposed Sale 49.68 3,100 154,001 Oct 22 04:16 PM Goldshleger Ilya See remarks Oct 18 '24 Option Exercise 15.08 3,105 46,823 45,351 Oct 18 05:23 PM Goldshleger Ilya See remarks Oct 16 '24 Option Exercise 15.08 3,100 46,748 45,346 Oct 18 05:23 PM Goldshleger Ilya See remarks Oct 18 '24 Sale 50.09 3,105 155,533 42,246 Oct 18 05:23 PM Goldshleger Ilya See remarks Oct 16 '24 Sale 49.78 3,100 154,318 42,246 Oct 18 05:23 PM ILYA GOLDSHLEGER Officer Oct 18 '24 Proposed Sale 50.09 3,105 155,533 Oct 18 04:23 PM ILYA GOLDSHLEGER Officer Oct 16 '24 Proposed Sale 49.78 3,100 154,317 Oct 16 04:16 PM Goldshleger Ilya See remarks Oct 10 '24 Option Exercise 15.08 3,105 46,823 45,351 Oct 15 04:23 PM Goldshleger Ilya See remarks Oct 11 '24 Option Exercise 15.08 3,100 46,748 45,346 Oct 15 04:23 PM Goldshleger Ilya See remarks Oct 14 '24 Option Exercise 15.08 3,100 46,748 45,346 Oct 15 04:23 PM Goldshleger Ilya See remarks Oct 11 '24 Sale 50.19 3,100 155,594 42,246 Oct 15 04:23 PM Goldshleger Ilya See remarks Oct 14 '24 Sale 50.09 3,100 155,268 42,246 Oct 15 04:23 PM Goldshleger Ilya See remarks Oct 10 '24 Sale 48.82 3,105 151,596 42,246 Oct 15 04:23 PM ILYA GOLDSHLEGER Officer Oct 14 '24 Proposed Sale 50.09 3,100 155,268 Oct 15 08:23 AM ILYA GOLDSHLEGER Officer Oct 11 '24 Proposed Sale 50.19 3,100 155,593 Oct 11 04:17 PM ILYA GOLDSHLEGER Officer Oct 10 '24 Proposed Sale 48.82 3,105 151,595 Oct 10 04:11 PM Goldshleger Ilya See remarks Oct 04 '24 Option Exercise 15.08 3,100 46,748 45,346 Oct 08 06:00 PM Goldshleger Ilya See remarks Oct 08 '24 Option Exercise 15.08 3,100 46,748 45,346 Oct 08 06:00 PM Goldshleger Ilya See remarks Oct 08 '24 Sale 48.26 3,100 149,612 42,246 Oct 08 06:00 PM Goldshleger Ilya See remarks Oct 04 '24 Sale 48.01 3,100 148,824 42,246 Oct 08 06:00 PM ILYA GOLDSHLEGER Officer Oct 08 '24 Proposed Sale 48.26 3,100 149,612 Oct 08 04:19 PM ILYA GOLDSHLEGER Officer Oct 04 '24 Proposed Sale 48.01 3,100 148,824 Oct 04 04:23 PM Thunen Shelley B See remarks Oct 01 '24 Option Exercise 16.00 15,000 240,000 45,443 Oct 02 04:11 PM Thunen Shelley B See remarks Oct 01 '24 Sale 48.45 15,000 726,730 30,443 Oct 02 04:11 PM SHELLEY B THUNEN Officer Oct 01 '24 Proposed Sale 48.45 15,000 726,729 Oct 01 04:24 PM Goldshleger Ilya See remarks Sep 26 '24 Option Exercise 15.08 3,105 46,823 45,351 Sep 30 08:05 PM Goldshleger Ilya See remarks Sep 30 '24 Option Exercise 15.08 3,100 46,748 45,346 Sep 30 08:05 PM Goldshleger Ilya See remarks Sep 26 '24 Sale 49.29 3,105 153,054 42,246 Sep 30 08:05 PM Goldshleger Ilya See remarks Sep 30 '24 Sale 49.02 3,100 151,947 42,246 Sep 30 08:05 PM ILYA GOLDSHLEGER Officer Sep 30 '24 Proposed Sale 49.02 3,100 151,946 Sep 30 04:14 PM ILYA GOLDSHLEGER Officer Sep 26 '24 Proposed Sale 49.29 3,105 153,054 Sep 26 04:09 PM Goldshleger Ilya See remarks Sep 20 '24 Option Exercise 15.08 3,100 46,748 45,346 Sep 23 06:48 PM Goldshleger Ilya See remarks Sep 23 '24 Option Exercise 15.08 3,100 46,748 45,346 Sep 23 06:48 PM Goldshleger Ilya See remarks Sep 20 '24 Sale 53.19 3,100 164,901 42,246 Sep 23 06:48 PM Goldshleger Ilya See remarks Sep 23 '24 Sale 52.67 3,100 163,263 42,246 Sep 23 06:48 PM ILYA GOLDSHLEGER Officer Sep 23 '24 Proposed Sale 52.67 3,100 163,263 Sep 23 04:08 PM ILYA GOLDSHLEGER Officer Sep 20 '24 Proposed Sale 53.19 3,100 164,901 Sep 20 04:08 PM Goldshleger Ilya See remarks Sep 17 '24 Option Exercise 15.08 3,100 46,748 45,346 Sep 18 04:41 PM Goldshleger Ilya See remarks Sep 17 '24 Sale 56.11 3,100 173,944 42,246 Sep 18 04:41 PM ILYA GOLDSHLEGER Officer Sep 17 '24 Proposed Sale 56.11 3,100 173,943 Sep 17 04:15 PM Kurtz Ronald M MD President & CEO Aug 09 '24 Option Exercise 12.60 9,950 125,355 63,450 Aug 09 05:57 PM Goldshleger Ilya See remarks Aug 05 '24 Sale 39.25 9,000 353,291 42,246 Aug 06 04:19 PM ILYA GOLDSHLEGER Officer Aug 05 '24 Proposed Sale 39.25 9,000 353,290 Aug 05 04:08 PM Thunen Shelley B See remarks Jul 15 '24 Option Exercise 4.34 16,505 71,632 30,443 Jul 16 08:15 PM Kurtz Ronald M MD President & CEO Jul 11 '24 Option Exercise 15.08 13,500 203,604 53,500 Jul 12 07:12 PM Thunen Shelley B Chief Financial Officer Jul 01 '24 Option Exercise 15.60 10,000 155,983 23,938 Jul 02 04:25 PM Thunen Shelley B Chief Financial Officer Jul 01 '24 Sale 58.61 10,000 586,055 13,938 Jul 02 04:25 PM Thunen Shelley B Chief Financial Officer Jul 01 '24 Sale 58.77 8,402 493,760 0 Jul 02 04:25 PM Andrews Julie Director Jun 14 '24 Sale 58.00 15,625 906,288 30,287 Jun 17 06:45 PM Tammenoms Bakker Juliet Director May 17 '24 Buy 61.09 5,000 305,456 34,840 May 21 04:11 PM Goldshleger Ilya Chief Operating Officer May 17 '24 Option Exercise 4.04 24,771 100,066 51,246 May 20 04:56 PM Kurtz Ronald M MD President & CEO May 03 '24 Sale 60.15 40,000 2,405,872 764,610 May 06 05:02 PM Thunen Shelley B Chief Financial Officer May 01 '24 Option Exercise 15.60 10,247 159,836 23,938 May 02 04:58 PM Thunen Shelley B Chief Financial Officer May 01 '24 Sale 52.69 10,000 526,913 13,938 May 02 04:58 PM Thunen Shelley B Chief Financial Officer Apr 01 '24 Sale 49.90 20,000 997,946 8,402 Apr 02 04:18 PM Thunen Shelley B Chief Financial Officer Mar 01 '24 Option Exercise 15.60 10,000 155,983 23,691 Mar 05 04:05 PM Thunen Shelley B Chief Financial Officer Mar 01 '24 Sale 56.37 10,000 563,726 13,691 Mar 05 04:05 PM Goldshleger Ilya Chief Operating Officer Feb 16 '24 Option Exercise 23.04 10,000 230,400 36,475 Feb 16 05:00 PM Goldshleger Ilya Chief Operating Officer Feb 15 '24 Option Exercise 23.04 10,000 230,400 36,475 Feb 16 05:00 PM Goldshleger Ilya Chief Operating Officer Feb 14 '24 Option Exercise 23.04 5,000 115,200 31,475 Feb 16 05:00 PM Goldshleger Ilya Chief Operating Officer Feb 16 '24 Sale 55.50 10,000 555,000 26,475 Feb 16 05:00 PM Goldshleger Ilya Chief Operating Officer Feb 15 '24 Sale 53.50 10,000 535,000 26,475 Feb 16 05:00 PM Goldshleger Ilya Chief Operating Officer Feb 14 '24 Sale 52.00 5,000 260,000 26,475 Feb 16 05:00 PM Tammenoms Bakker Juliet Director Feb 14 '24 Buy 51.29 4,000 205,153 29,840 Feb 15 04:15 PM Tammenoms Bakker Juliet Director Feb 12 '24 Buy 50.38 4,000 201,520 25,840 Feb 15 04:15 PM Goldshleger Ilya Chief Operating Officer Feb 09 '24 Option Exercise 20.90 10,365 216,598 36,840 Feb 12 06:02 PM Goldshleger Ilya Chief Operating Officer Feb 09 '24 Sale 50.74 10,365 525,939 26,475 Feb 12 06:02 PM Thunen Shelley B Chief Financial Officer Feb 06 '24 Option Exercise 14.95 15,875 237,331 29,566 Feb 07 05:18 PM Thunen Shelley B Chief Financial Officer Feb 05 '24 Option Exercise 10.38 16,025 166,365 22,816 Feb 07 05:18 PM Thunen Shelley B Chief Financial Officer Feb 06 '24 Sale 47.47 15,875 753,574 13,691 Feb 07 05:18 PM Thunen Shelley B Chief Financial Officer Feb 05 '24 Sale 47.02 9,125 429,087 13,691 Feb 07 05:18 PM LINK WILLIAM J PHD Director Feb 01 '24 Sale 49.67 28,250 1,403,120 24,248 Feb 02 04:49 PM Goldshleger Ilya Chief Operating Officer Feb 01 '24 Option Exercise 19.24 7,129 137,181 33,604 Feb 02 04:47 PM Goldshleger Ilya Chief Operating Officer Feb 01 '24 Sale 49.29 7,129 351,411 26,475 Feb 02 04:47 PM Weinberg Eric Chief Commercial Officer Feb 01 '24 Sale 50.00 10,000 500,004 299,978 Feb 02 04:47 PM Thunen Shelley B Chief Financial Officer Jan 26 '24 Option Exercise 13.75 36,272 498,652 38,563 Jan 29 05:36 PM Thunen Shelley B Chief Financial Officer Jan 26 '24 Sale 47.11 31,772 1,496,706 6,791 Jan 29 05:36 PM Weinberg Eric Chief Commercial Officer Jan 22 '24 Sale 48.00 10,000 480,006 309,978 Jan 22 07:50 PM Goldshleger Ilya Chief Operating Officer Jan 22 '24 Option Exercise 18.90 5,000 94,500 31,475 Jan 22 07:48 PM Goldshleger Ilya Chief Operating Officer Jan 22 '24 Sale 48.00 5,000 240,000 26,475 Jan 22 07:48 PM Maniar Shweta Director Jan 18 '24 Sale 45.72 6,399 292,555 12,130 Jan 19 04:01 PM Goldshleger Ilya Chief Operating Officer Jan 09 '24 Option Exercise 18.90 5,000 94,500 31,475 Jan 10 05:29 PM Goldshleger Ilya Chief Operating Officer Jan 09 '24 Sale 47.00 5,000 235,000 26,475 Jan 10 05:29 PM Weinberg Eric Chief Commercial Officer Jan 09 '24 Sale 46.00 10,000 460,000 319,978 Jan 10 05:28 PM Weinberg Eric Chief Commercial Officer Jan 08 '24 Sale 42.00 10,000 420,000 329,978 Jan 09 04:12 PM Warner Robert Keith Director Jan 08 '24 Sale 42.69 23,750 1,013,894 0 Jan 09 04:10 PM Maniar Shweta Director Jan 08 '24 Sale 45.00 6,418 288,810 18,529 Jan 09 04:09 PM Kurtz Ronald M MD President & CEO Jan 08 '24 Sale 44.25 62,500 2,765,631 804,610 Jan 09 04:08 PM Goldshleger Ilya Chief Operating Officer Jan 08 '24 Option Exercise 15.08 15,000 226,200 41,475 Jan 09 04:05 PM Goldshleger Ilya Chief Operating Officer Jan 08 '24 Sale 43.33 15,000 650,000 26,475 Jan 09 04:05 PM Corley Jesse Anderson Director Jan 08 '24 Sale 45.03 2,000 90,059 11,625 Jan 09 04:02 PM Thunen Shelley B Chief Financial Officer Jan 02 '24 Option Exercise 15.60 10,000 155,983 12,291 Jan 03 04:11 PM Thunen Shelley B Chief Financial Officer Jan 02 '24 Sale 39.24 10,000 392,409 2,291 Jan 03 04:11 PM Kurtz Ronald M MD President & CEO Dec 27 '23 Sale 41.09 22,500 924,498 867,110 Dec 29 04:57 PM Weinberg Eric Chief Commercial Officer Dec 22 '23 Sale 40.00 1,285 51,400 339,978 Dec 26 04:11 PM Goldshleger Ilya Chief Operating Officer Dec 22 '23 Option Exercise 15.08 5,000 75,400 31,475 Dec 26 04:10 PM Goldshleger Ilya Chief Operating Officer Dec 22 '23 Sale 40.00 5,000 200,000 26,475 Dec 26 04:10 PM Goldshleger Ilya Chief Operating Officer Dec 18 '23 Option Exercise 14.14 10,937 154,670 37,412 Dec 20 06:07 PM
Index -
P/E -
EPS (ttm) -11.02
Insider Own 83.53%
Shs Outstand 0.65M
Perf Week -7.66%
Market Cap 10.97M
Forward P/E -
EPS next Y -2.78
Insider Trans 104.06%
Shs Float 0.26M
Perf Month -22.76%
Income -7.86M
PEG -
EPS next Q -1.36
Inst Own 1.11%
Short Float 36.01%
Perf Quarter 32.89%
Sales 1.53M
P/S 7.17
EPS this Y 40.94%
Inst Trans 162.14%
Short Ratio 0.06
Perf Half Y 37.33%
Book/sh 4.81
P/B 1.45
EPS next Y 63.23%
ROA -91.45%
Short Interest 0.09M
Perf Year -20.57%
Cash/sh 3.76
P/C 1.86
EPS next 5Y -
ROE -96.53%
52W Range 3.26 - 27.20
Perf YTD -17.16%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -107.09%
52W High -74.30%
Beta 2.80
Dividend TTM -
Quick Ratio 12.71
Sales past 5Y 393.99%
Gross Margin -2.46%
52W Low 114.42%
ATR (14) 0.85
Dividend Ex-Date -
Current Ratio 14.73
EPS Y/Y TTM 30.12%
Oper. Margin -528.26%
RSI (14) 47.32
Volatility 8.95% 12.01%
Employees 11
Debt/Eq 0.00
Sales Y/Y TTM 186.54%
Profit Margin -514.09%
Recom 1.00
Target Price 14.00
Option/Short No / Yes
LT Debt/Eq 0.00
EPS Q/Q 37.91%
Payout -
Rel Volume 0.02
Prev Close 6.69
Sales Surprise 0.00%
EPS Surprise 0.00%
Sales Q/Q 81.65%
Earnings Aug 28
Avg Volume 1.59M
Price 6.99
SMA20 -10.61%
SMA50 9.91%
SMA200 0.50%
Trades
Volume 34,684
Change 4.48%
Oct-14-24 08:30AM
Oct-02-24 12:07PM
Sep-25-24 08:20PM
Sep-23-24 08:00AM
Sep-17-24 08:30AM
08:30AM
Loading…
Sep-05-24 08:30AM
Sep-04-24 05:49PM
Sep-03-24 08:39AM
Aug-29-24 08:00AM
Aug-21-24 08:00AM
Aug-13-24 08:00AM
Aug-01-24 10:22AM
Jul-18-24 08:00AM
Jun-14-24 08:30AM
Jun-13-24 08:30AM
06:40AM
Loading…
Jun-07-24 06:40AM
Jun-03-24 08:00AM
May-30-24 07:47AM
May-29-24 04:15PM
12:15PM
11:58AM
09:00AM
07:39AM
May-28-24 02:43PM
07:27AM
May-24-24 04:02PM
07:16AM
May-14-24 01:53PM
08:30AM
May-01-24 05:00PM
04:30PM
Loading…
04:30PM
Apr-29-24 08:00AM
Apr-25-24 08:32AM
Apr-24-24 08:30AM
Apr-18-24 08:30AM
Apr-17-24 08:30AM
Mar-25-24 01:53PM
08:30AM
Feb-01-24 09:00AM
Jan-22-24 08:00AM
Jan-11-24 08:00AM
Jan-10-24 08:00AM
Jan-05-24 10:04AM
Dec-14-23 08:30AM
Dec-13-23 09:00AM
Dec-12-23 08:30AM
Dec-11-23 08:30AM
Nov-16-23 07:00AM
Oct-17-23 07:00AM
Oct-03-23 08:00AM
Sep-22-23 03:05PM
Sep-21-23 09:35AM
Sep-11-23 07:00AM
Aug-15-23 10:20AM
Aug-14-23 07:00AM
Aug-03-23 09:25AM
08:30AM
08:00AM
Aug-02-23 02:26PM
Aug-01-23 08:00AM
Jun-30-23 07:00AM
Jun-28-23 07:00AM
Jun-26-23 02:44PM
Jun-22-23 08:15AM
Jun-20-23 07:00AM
May-09-23 07:15AM
Apr-14-23 07:00AM
Apr-12-23 08:52AM
07:00AM
Apr-11-23 07:00AM
Mar-02-23 07:00AM
Feb-23-23 11:18AM
Feb-07-23 02:00AM
Feb-06-23 02:00AM
Dec-28-22 07:00AM
Dec-27-22 07:00AM
Nov-16-22 05:47AM
Oct-25-22 08:05AM
Oct-11-22 02:00AM
Oct-03-22 02:00AM
Aug-18-22 07:00AM
Aug-17-22 01:16PM
Aug-14-22 06:35PM
Innovative Eyewear, Inc. retails eye glasses online. It designs and provides smart glasses enhanced with tech features such as built-in Bluetooth audio connectivity, phone control buttons and instant AI voice assistant access. The company was founded by Harrison Gross, Konrad Dabrowski and David Eric Cohen in 2019 and is headquartered in Miami, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Galkin Vladimir 10% Owner Sep 23 '24 Buy 9.08 200,792 1,822,973 1,000,000 Sep 26 08:31 AM Galkin Vladimir 10% Owner Sep 20 '24 Buy 10.31 70,000 721,472 813,245 Sep 24 03:28 PM Galkin Vladimir 10% Owner Sep 20 '24 Sale 10.61 14,037 148,896 799,208 Sep 24 03:28 PM Galkin Vladimir 10% Owner Sep 19 '24 Buy 8.91 297,443 2,649,148 785,573 Sep 24 02:51 PM Galkin Vladimir 10% Owner Sep 19 '24 Sale 9.07 42,328 384,100 743,245 Sep 24 02:51 PM Galkin Vladimir 10% Owner Sep 18 '24 Buy 7.79 128,130 997,896 548,130 Sep 24 12:25 PM Galkin Vladimir 10% Owner Sep 18 '24 Sale 8.17 60,000 490,400 488,130 Sep 24 12:25 PM Galkin Vladimir 10% Owner Sep 17 '24 Buy 7.12 346,736 2,469,387 678,483 Sep 24 12:00 PM Galkin Vladimir 10% Owner Sep 17 '24 Sale 7.27 258,483 1,879,632 420,000 Sep 24 12:00 PM Gross Harrison R. Chief Executive Officer Aug 19 '24 Buy 3.68 500 1,840 500 Aug 21 01:48 PM
Index S&P 500
P/E 58.96
EPS (ttm) 1.79
Insider Own 0.51%
Shs Outstand 199.16M
Perf Week -2.51%
Market Cap 21.08B
Forward P/E 25.93
EPS next Y 4.08
Insider Trans -20.15%
Shs Float 198.15M
Perf Month -3.62%
Income 359.30M
PEG 4.74
EPS next Q 1.00
Inst Own 98.69%
Short Float 0.85%
Perf Quarter 15.05%
Sales 3.80B
P/S 5.54
EPS this Y 14.13%
Inst Trans 1.24%
Short Ratio 1.57
Perf Half Y 15.43%
Book/sh 39.80
P/B 2.66
EPS next Y 11.69%
ROA 3.02%
Short Interest 1.68M
Perf Year 30.47%
Cash/sh 0.55
P/C 191.96
EPS next 5Y 12.43%
ROE 4.65%
52W Range 75.93 - 112.38
Perf YTD 11.86%
Dividend Est. 0.02 (0.02%)
P/FCF 111.40
EPS past 5Y 15.98%
ROI 3.42%
52W High -5.82%
Beta 0.98
Dividend TTM -
Quick Ratio 1.18
Sales past 5Y 7.68%
Gross Margin 61.17%
52W Low 39.37%
ATR (14) 1.79
Dividend Ex-Date Jul 26, 2023
Current Ratio 1.99
EPS Y/Y TTM 29.89%
Oper. Margin 16.90%
RSI (14) 46.14
Volatility 1.55% 1.52%
Employees 15000
Debt/Eq 0.33
Sales Y/Y TTM 8.25%
Profit Margin 9.45%
Recom 1.95
Target Price 115.93
Option/Short Yes / Yes
LT Debt/Eq 0.33
EPS Q/Q 22.11%
Payout 1.02%
Rel Volume 1.91
Prev Close 106.72
Sales Surprise 0.55%
EPS Surprise 5.38%
Sales Q/Q 7.80%
Earnings Aug 28 AMC
Avg Volume 1.07M
Price 105.83
SMA20 -1.57%
SMA50 1.17%
SMA200 9.35%
Trades
Volume 1,999,677
Change -0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-29-24 Reiterated
Piper Sandler
Overweight
$115 → $120
Jul-16-24 Upgrade
Jefferies
Hold → Buy
$107 → $115
Mar-19-24 Upgrade
Redburn Atlantic
Neutral → Buy
$125
Mar-13-24 Upgrade
JP Morgan
Neutral → Overweight
$100 → $120
Feb-06-24 Resumed
KeyBanc Capital Markets
Sector Weight
Oct-30-23 Initiated
BofA Securities
Buy
$380
Oct-05-23 Downgrade
Redburn Atlantic
Overweight → Neutral
$390 → $343
May-30-23 Initiated
Morgan Stanley
Equal-Weight
$410
Dec-22-22 Initiated
Mizuho
Buy
$375
Nov-30-22 Upgrade
Robert W. Baird
Neutral → Outperform
$345 → $375
Oct-12-22 Downgrade
Jefferies
Buy → Hold
$400 → $295
Aug-29-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
May-17-22 Upgrade
Citigroup
Neutral → Buy
$460 → $405
Apr-08-22 Initiated
Needham
Hold
Jan-03-22 Upgrade
Guggenheim
Neutral → Buy
Sep-03-21 Reiterated
Stifel
Buy
$450 → $475
Sep-03-21 Reiterated
Oppenheimer
Perform
$405 → $475
Sep-03-21 Reiterated
KeyBanc Capital Markets
Overweight
$444 → $476
Sep-03-21 Reiterated
Citigroup
Neutral
$400 → $453
Apr-23-21 Initiated
Redburn
Buy
Show Previous Ratings
Sep-19-24 12:00PM
Sep-12-24 09:55AM
Sep-10-24 04:28PM
Sep-03-24 04:15PM
Sep-02-24 09:15AM
01:24AM
Loading…
Aug-30-24 01:24AM
Aug-29-24 06:35PM
11:06AM
10:52AM
(Thomson Reuters StreetEvents)
Aug-28-24 06:00PM
05:25PM
04:26PM
(Associated Press Finance)
04:15PM
Aug-27-24 09:02AM
Aug-26-24 12:10PM
08:28AM
Loading…
08:28AM
Aug-23-24 12:00PM
09:15AM
Aug-08-24 04:15PM
Aug-06-24 04:15PM
Aug-01-24 04:15PM
Jul-24-24 08:04AM
Jul-15-24 02:00AM
Jun-18-24 07:54AM
Jun-01-24 01:04AM
May-31-24 11:41AM
May-30-24 08:53PM
06:00PM
05:25PM
04:25PM
(Associated Press Finance)
04:15PM
Loading…
04:15PM
May-28-24 07:45PM
09:53AM
May-24-24 09:15AM
May-23-24 04:15PM
May-20-24 03:57PM
May-15-24 07:54PM
04:15PM
May-14-24 04:15PM
06:51AM
Apr-30-24 04:15PM
Apr-24-24 12:00PM
Apr-12-24 09:22AM
Mar-25-24 02:16PM
Mar-11-24 08:27AM
Mar-08-24 02:37PM
Mar-01-24 10:41AM
(Morningstar Research) +9.18%
07:07AM
Feb-29-24 04:15PM
Feb-26-24 09:16AM
Feb-22-24 10:00AM
Feb-21-24 08:01PM
Feb-20-24 11:35AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
Feb-13-24 09:43AM
Feb-12-24 10:31AM
08:02AM
Feb-09-24 08:31AM
Jan-25-24 04:15PM
Jan-22-24 04:53AM
Jan-05-24 07:48AM
Dec-21-23 04:15PM
Dec-19-23 04:15PM
Dec-09-23 01:05AM
Dec-08-23 02:11PM
12:57PM
(Associated Press Finance)
09:17AM
09:14AM
07:15AM
(Thomson Reuters StreetEvents)
Dec-07-23 06:00PM
05:10PM
04:58PM
04:36PM
(Associated Press Finance)
04:15PM
Dec-05-23 02:20PM
Dec-04-23 12:44PM
Nov-30-23 04:15PM
10:00AM
Nov-28-23 09:31AM
Nov-24-23 01:25AM
Nov-02-23 04:15PM
Nov-01-23 04:15PM
Oct-30-23 09:43AM
Oct-19-23 11:40AM
Oct-13-23 11:33AM
07:36AM
Sep-27-23 12:03PM
Sep-14-23 12:30PM
Sep-12-23 04:15PM
Sep-11-23 04:15PM
Sep-08-23 03:44PM
Sep-05-23 12:03PM
Aug-31-23 12:06PM
11:35AM
10:14AM
08:39AM
08:19AM
06:41AM
(Thomson Reuters StreetEvents)
Aug-30-23 06:00PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
White Albert G III President & CEO Sep 19 '24 Option Exercise 43.83 114,992 5,040,099 280,265 Sep 20 05:51 PM White Albert G III President & CEO Sep 19 '24 Sale 110.53 114,992 12,710,041 165,273 Sep 20 05:51 PM Albert G. White III Officer Sep 19 '24 Proposed Sale 110.53 114,992 12,709,660 Sep 19 03:53 PM Ricupati Agostino SVP & CAO Apr 01 '24 Option Exercise 0.00 2,076 0 7,472 Sep 11 05:50 PM Ricupati Agostino SVP & CAO Sep 10 '24 Sale 108.03 1,601 172,955 4,818 Sep 11 05:50 PM Agostino Ricupati Director Sep 10 '24 Proposed Sale 108.03 1,601 172,950 Sep 10 01:47 PM Andrews Brian G EVP, CFO & Treasurer Sep 05 '24 Option Exercise 37.91 24,788 939,734 31,402 Sep 06 04:58 PM Andrews Brian G EVP, CFO & Treasurer Sep 05 '24 Sale 105.90 24,788 2,625,072 6,614 Sep 06 04:58 PM McBride Daniel G EVP & Chief Operating Officer Sep 04 '24 Option Exercise 43.83 114,992 5,040,099 159,688 Sep 06 04:56 PM McBride Daniel G EVP & Chief Operating Officer Sep 04 '24 Sale 105.48 114,992 12,129,911 44,696 Sep 06 04:56 PM Brian G. Andrews Officer Sep 05 '24 Proposed Sale 105.90 24,788 2,624,952 Sep 05 01:22 PM Daniel McBride Officer Sep 04 '24 Proposed Sale 105.48 114,992 12,129,545 Sep 04 04:18 PM WEISS ROBERT S Director Apr 01 '24 Option Exercise 0.00 3,180 0 285,952 Apr 03 06:03 PM Rivas Maria Director Apr 01 '24 Option Exercise 0.00 2,892 0 2,892 Apr 03 06:03 PM MADDEN TERESA S Director Apr 01 '24 Option Exercise 0.00 2,892 0 9,636 Apr 03 05:53 PM Lucchese Cynthia L Director Apr 01 '24 Option Exercise 0.00 2,892 0 4,940 Apr 03 05:53 PM Jay Colleen Director Apr 01 '24 Option Exercise 0.00 2,892 0 26,800 Apr 03 05:53 PM Kurzius Lawrence Erik Director Apr 01 '24 Option Exercise 0.00 1,056 0 1,056 Apr 03 05:52 PM KOZY WILLIAM A Director Apr 01 '24 Option Exercise 0.00 3,036 0 28,292 Apr 03 05:52 PM Ricupati Agostino SVP & CAO Mar 18 '24 Option Exercise 69.74 54,724 3,816,317 34,609 Mar 20 06:58 PM Ricupati Agostino SVP & CAO Mar 18 '24 Sale 100.89 54,724 5,521,230 5,081 Mar 20 06:58 PM WEISS ROBERT S Director Mar 07 '24 Option Exercise 57.41 153,213 8,796,724 435,985 Mar 11 05:00 PM WEISS ROBERT S Director Mar 08 '24 Option Exercise 57.41 88,075 5,056,826 370,847 Mar 11 05:00 PM WEISS ROBERT S Director Mar 07 '24 Sale 102.21 153,213 15,659,610 282,772 Mar 11 05:00 PM WEISS ROBERT S Director Mar 08 '24 Sale 102.18 88,075 8,999,732 282,772 Mar 11 05:00 PM PETERSMEYER GARY S Director Mar 05 '24 Sale 103.51 1,000 103,506 5,668 Mar 07 06:05 PM Sheffield Holly R President, CSI Jan 08 '24 Option Exercise 0.00 986 0 5,564 Jan 10 07:11 PM Khadder Nicholas VP, General Counsel & Corp Sec Jan 08 '24 Option Exercise 0.00 284 0 325 Jan 10 07:11 PM Ricupati Agostino SVP & CAO Jan 08 '24 Option Exercise 0.00 786 0 1,710 Jan 10 07:11 PM McBride Daniel G EVP & Chief Operating Officer Jan 08 '24 Option Exercise 0.00 1,042 0 9,368 Jan 10 07:11 PM Warner Gerard H III President, CooperVision, Inc. Jan 08 '24 Option Exercise 0.00 2,738 0 4,028 Jan 10 07:11 PM Andrews Brian G EVP, CFO & Treasurer Jan 08 '24 Option Exercise 0.00 723 0 2,996 Jan 10 07:11 PM PETERSMEYER GARY S Director Jan 04 '24 Sale 336.03 150 50,404 2,297 Jan 05 06:05 PM WEISS ROBERT S Director Dec 19 '23 Option Exercise 175.31 79,370 13,914,355 150,063 Dec 21 05:25 PM WEISS ROBERT S Director Dec 19 '23 Sale 364.81 79,370 28,955,135 70,693 Dec 21 05:25 PM PETERSMEYER GARY S Director Dec 14 '23 Sale 368.55 300 110,565 2,464 Dec 14 07:15 PM
Index RUT
P/E -
EPS (ttm) -0.39
Insider Own 26.96%
Shs Outstand 98.37M
Perf Week 13.87%
Market Cap 2.13B
Forward P/E 55.97
EPS next Y 0.32
Insider Trans -15.78%
Shs Float 87.53M
Perf Month 23.25%
Income -45.90M
PEG -
EPS next Q 0.05
Inst Own 76.22%
Short Float 15.60%
Perf Quarter 8.60%
Sales 719.93M
P/S 2.96
EPS this Y 138.39%
Inst Trans 4.78%
Short Ratio 8.17
Perf Half Y 32.91%
Book/sh 2.75
P/B 6.48
EPS next Y 33.48%
ROA -7.78%
Short Interest 13.65M
Perf Year 27.21%
Cash/sh 1.99
P/C 8.97
EPS next 5Y -
ROE -14.54%
52W Range 9.83 - 18.21
Perf YTD 26.31%
Dividend Est. -
P/FCF 88.93
EPS past 5Y -1.04%
ROI -9.25%
52W High -2.20%
Beta 1.83
Dividend TTM -
Quick Ratio 2.08
Sales past 5Y 16.55%
Gross Margin 53.94%
52W Low 81.18%
ATR (14) 0.73
Dividend Ex-Date -
Current Ratio 2.52
EPS Y/Y TTM 36.69%
Oper. Margin -7.70%
RSI (14) 66.14
Volatility 4.34% 4.28%
Employees 3491
Debt/Eq 0.58
Sales Y/Y TTM 13.67%
Profit Margin -6.38%
Recom 1.93
Target Price 17.15
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 58.72%
Payout -
Rel Volume 1.04
Prev Close 18.20
Sales Surprise 0.64%
EPS Surprise 67.50%
Sales Q/Q 13.32%
Earnings Nov 07 BMO
Avg Volume 1.67M
Price 17.81
SMA20 10.84%
SMA50 18.51%
SMA200 22.62%
Trades
Volume 1,726,129
Change -2.14%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-21-24 Upgrade
Goldman
Neutral → Buy
$15 → $18
Aug-23-24 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
$20
Aug-23-24 Resumed
Piper Sandler
Overweight
$18
Oct-12-23 Upgrade
BTIG Research
Neutral → Buy
$17
Oct-03-23 Upgrade
Evercore ISI
In-line → Outperform
$20
Sep-25-23 Initiated
UBS
Neutral
$13
Jun-27-23 Initiated
William Blair
Mkt Perform
May-24-23 Initiated
JMP Securities
Mkt Perform
Mar-01-23 Downgrade
Citigroup
Buy → Neutral
$26 → $13
Feb-07-23 Initiated
BTIG Research
Neutral
Dec-15-22 Initiated
Wolfe Research
Outperform
$20
Jul-22-22 Initiated
Piper Sandler
Overweight
$20
May-18-22 Downgrade
Goldman
Buy → Neutral
$34 → $18
Mar-31-22 Initiated
Stifel
Hold
$36
Oct-26-21 Initiated
Citigroup
Buy
$67
Oct-25-21 Initiated
Telsey Advisory Group
Outperform
$66
Oct-25-21 Initiated
Robert W. Baird
Outperform
$68
Oct-25-21 Initiated
Morgan Stanley
Equal-Weight
$57
Oct-25-21 Initiated
Goldman
Buy
$72
Oct-25-21 Initiated
Evercore ISI
In-line
$54
Show Previous Ratings
Oct-21-24 04:03PM
(Yahoo Finance Video) +9.97%
10:47AM
Oct-17-24 07:00AM
Oct-09-24 05:33PM
Oct-05-24 11:09AM
02:26PM
Loading…
Sep-29-24 02:26PM
Sep-18-24 10:34AM
Sep-13-24 07:01PM
Sep-12-24 01:19AM
Sep-03-24 08:00AM
Aug-29-24 06:01AM
Aug-09-24 07:06AM
Aug-08-24 03:45PM
02:03PM
09:30AM
07:55AM
Loading…
07:55AM
06:45AM
Aug-01-24 04:15PM
Jul-18-24 07:00AM
Jun-27-24 10:36AM
Jun-07-24 01:01PM
Jun-05-24 08:36PM
Jun-01-24 06:44AM
May-31-24 07:30AM
May-27-24 12:20PM
12:00PM
May-26-24 08:02AM
May-16-24 05:23PM
May-13-24 01:19PM
10:18AM
09:18AM
Loading…
09:18AM
May-10-24 03:42PM
02:33PM
01:33PM
01:30PM
11:08AM
06:48AM
12:58AM
(Thomson Reuters StreetEvents)
May-09-24 10:45PM
12:47PM
09:45AM
09:30AM
08:51AM
08:47AM
06:45AM
May-01-24 11:10AM
Apr-18-24 04:05PM
Apr-17-24 09:00AM
Mar-20-24 10:09AM
Mar-08-24 11:54PM
Mar-06-24 11:30PM
Mar-05-24 10:55AM
Feb-29-24 04:47PM
Feb-28-24 11:16PM
(Thomson Reuters StreetEvents) -14.96%
07:15PM
04:30PM
12:11PM
10:30AM
09:30AM
07:13AM
07:10AM
06:49AM
Feb-08-24 04:05PM
Jan-27-24 01:02PM
Jan-22-24 02:29PM
Jan-15-24 05:30AM
(The Wall Street Journal)
Dec-13-23 09:36PM
Dec-10-23 06:30AM
Dec-04-23 07:00AM
Nov-10-23 04:03PM
Nov-08-23 04:17PM
(Motley Fool) -23.99%
-6.53%
03:11PM
01:15PM
09:30AM
08:03AM
06:45AM
Oct-18-23 04:05PM
Oct-12-23 09:49AM
Oct-03-23 10:27AM
09:54AM
09:45AM
01:18AM
Sep-07-23 04:05PM
Aug-27-23 08:00AM
Aug-23-23 09:02PM
Aug-20-23 10:00AM
(The Wall Street Journal)
Aug-12-23 08:05AM
Aug-09-23 03:00PM
10:21AM
10:15AM
09:30AM
08:05AM
06:45AM
Aug-03-23 05:55PM
Jul-23-23 12:11PM
08:09AM
Jul-19-23 08:30AM
Jun-29-23 04:49PM
Jun-05-23 08:00AM
May-16-23 09:21AM
Warby Parker, Inc. operates as an online retailer of eyewear for men and women. It engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Miller Steven Clive Chief Financial Officer Sep 11 '24 Sale 13.90 6,763 94,006 177,488 Sep 13 05:00 PM STEVE MILLER Officer Sep 11 '24 Proposed Sale 13.88 6,763 93,870 Sep 11 04:18 PM Miller Steven Clive Chief Financial Officer Sep 06 '24 Option Exercise 0.00 26,511 0 199,523 Sep 10 08:21 PM Miller Steven Clive Chief Financial Officer Sep 06 '24 Sale 13.00 15,272 198,536 184,251 Sep 10 08:21 PM Blumenthal Neil Harris Co-Chief Executive Officer Sep 09 '24 Sale 13.89 50,000 694,625 12,177 Sep 10 08:20 PM Blumenthal Neil Harris Co-Chief Executive Officer Sep 06 '24 Sale 13.00 27,143 352,859 12,177 Sep 10 08:20 PM Gilboa David Abraham Co-Chief Executive Officer Sep 10 '24 Sale 13.69 49,034 671,275 12,306 Sep 10 08:19 PM Gilboa David Abraham Co-Chief Executive Officer Sep 06 '24 Sale 13.00 27,143 352,859 12,306 Sep 10 08:19 PM DAVID GILBOA Director Sep 10 '24 Proposed Sale 13.91 49,034 682,063 Sep 10 04:22 PM NEIL BLUMENTHAL Director Sep 09 '24 Proposed Sale 13.10 50,000 655,000 Sep 09 04:28 PM David Abraham Gilboa Director, Officer Sep 06 '24 Proposed Sale 12.69 27,812 352,924 Sep 06 07:34 PM Steven Clive Miller Officer Sep 06 '24 Proposed Sale 12.69 15,643 198,504 Sep 06 07:33 PM Neil Harris Blumenthal Director, Officer Sep 06 '24 Proposed Sale 12.69 27,812 352,924 Sep 06 07:28 PM SINGER BRADLEY E Director Aug 13 '24 Buy 13.00 50,000 650,000 100,000 Aug 14 04:52 PM SINGER BRADLEY E Director Aug 14 '24 Buy 12.63 25,000 315,750 125,000 Aug 14 04:52 PM D1 Capital Partners L.P. 10% Owner Jun 14 '24 Sale 15.66 5,500,000 86,130,000 9,444,023 Jun 18 04:15 PM Briggs Teresa Director Jun 13 '24 Sale 16.31 7,396 120,629 38,859 Jun 17 05:04 PM Miller Steven Clive Chief Financial Officer Jun 12 '24 Option Exercise 13.35 99,816 1,332,544 272,828 Jun 13 05:26 PM Miller Steven Clive Chief Financial Officer Jun 12 '24 Sale 16.61 99,816 1,657,944 173,012 Jun 13 05:26 PM Miller Steven Clive Chief Financial Officer Jun 11 '24 Sale 16.59 9,394 155,846 173,012 Jun 13 05:26 PM Blumenthal Neil Harris Co-Chief Executive Officer Jun 07 '24 Sale 16.65 76,582 1,275,122 12,177 Jun 11 09:54 PM Gilboa David Abraham Co-Chief Executive Officer Jun 10 '24 Sale 16.69 149,034 2,487,377 12,306 Jun 11 09:29 PM Gilboa David Abraham Co-Chief Executive Officer Jun 07 '24 Sale 16.67 26,582 443,122 12,306 Jun 11 09:29 PM Miller Steven Clive Chief Financial Officer Jun 07 '24 Option Exercise 12.35 58,455 721,919 225,334 Jun 10 08:02 PM Miller Steven Clive Chief Financial Officer Jun 06 '24 Option Exercise 13.04 11,263 146,837 182,588 Jun 10 08:02 PM Miller Steven Clive Chief Financial Officer Jun 07 '24 Sale 16.54 69,439 1,148,429 166,879 Jun 10 08:02 PM Miller Steven Clive Chief Financial Officer Jun 06 '24 Sale 17.04 15,709 267,619 166,879 Jun 10 08:02 PM Miller Steven Clive Chief Financial Officer Mar 11 '24 Sale 11.98 24,225 290,216 166,879 Mar 13 04:33 PM Gilboa David Abraham Co-Chief Executive Officer Mar 08 '24 Sale 12.20 52,065 635,193 12,306 Mar 08 06:19 PM Gilboa David Abraham Co-Chief Executive Officer Mar 06 '24 Sale 11.88 28,311 336,335 12,306 Mar 08 06:19 PM Miller Steven Clive Chief Financial Officer Mar 06 '24 Option Exercise 0.00 21,159 0 199,812 Mar 08 06:18 PM Miller Steven Clive Chief Financial Officer Mar 06 '24 Sale 11.88 8,708 103,451 191,104 Mar 08 06:18 PM Blumenthal Neil Harris Co-Chief Executive Officer Mar 07 '24 Sale 12.40 50,000 620,000 12,177 Mar 08 06:16 PM Blumenthal Neil Harris Co-Chief Executive Officer Mar 06 '24 Sale 11.88 28,311 336,335 12,177 Mar 08 06:16 PM Miller Steven Clive Chief Financial Officer Mar 05 '24 Sale 12.12 8,963 108,632 178,653 Mar 06 05:08 PM Gilboa David Abraham Co-Chief Executive Officer Mar 05 '24 Sale 12.12 16,731 202,780 12,306 Mar 06 05:07 PM Blumenthal Neil Harris Co-Chief Executive Officer Mar 05 '24 Sale 12.12 16,731 202,780 12,177 Mar 06 05:05 PM Miller Steven Clive Chief Financial Officer Dec 14 '23 Sale 12.22 10,875 132,892 166,879 Dec 18 05:30 PM Blumenthal Neil Harris Co-Chief Executive Officer Dec 08 '23 Sale 10.56 56,038 591,761 106 Dec 12 05:32 PM Gilboa David Abraham Co-Chief Executive Office Dec 08 '23 Sale 10.56 56,038 591,761 235 Dec 12 05:31 PM Miller Steven Clive Chief Financial Officer Dec 08 '23 Option Exercise 0.00 18,480 0 207,064 Dec 12 05:30 PM Miller Steven Clive Chief Financial Officer Dec 11 '23 Sale 11.42 21,550 246,101 177,754 Dec 12 05:30 PM Miller Steven Clive Chief Financial Officer Dec 08 '23 Sale 10.56 7,760 81,946 199,304 Dec 12 05:30 PM
Index RUT
P/E -
EPS (ttm) -1.04
Insider Own 2.17%
Shs Outstand 78.31M
Perf Week -5.93%
Market Cap 761.24M
Forward P/E 18.26
EPS next Y 0.53
Insider Trans 3.79%
Shs Float 76.93M
Perf Month -8.77%
Income -81.22M
PEG -
EPS next Q 0.06
Inst Own 105.11%
Short Float 7.72%
Perf Quarter -26.89%
Sales 2.03B
P/S 0.37
EPS this Y -27.47%
Inst Trans -3.13%
Short Ratio 3.11
Perf Half Y -48.62%
Book/sh 10.73
P/B 0.90
EPS next Y 14.17%
ROA -3.51%
Short Interest 5.94M
Perf Year -38.54%
Cash/sh 2.28
P/C 4.24
EPS next 5Y 17.20%
ROE -8.97%
52W Range 9.60 - 24.11
Perf YTD -53.75%
Dividend Est. -
P/FCF 21.41
EPS past 5Y -
ROI -5.93%
52W High -59.85%
Beta 1.41
Dividend TTM -
Quick Ratio 0.41
Sales past 5Y 7.09%
Gross Margin 49.04%
52W Low 0.78%
ATR (14) 0.37
Dividend Ex-Date -
Current Ratio 0.55
EPS Y/Y TTM -412.61%
Oper. Margin 1.02%
RSI (14) 36.53
Volatility 2.88% 3.18%
Employees 13998
Debt/Eq 1.10
Sales Y/Y TTM -1.11%
Profit Margin -4.00%
Recom 2.36
Target Price 13.70
Option/Short Yes / Yes
LT Debt/Eq 0.62
EPS Q/Q -155.51%
Payout -
Rel Volume 0.53
Prev Close 9.85
Sales Surprise 0.08%
EPS Surprise 59.74%
Sales Q/Q -14.01%
Earnings Aug 07 BMO
Avg Volume 1.91M
Price 9.68
SMA20 -5.88%
SMA50 -7.19%
SMA200 -38.43%
Trades
Volume 1,156,307
Change -1.73%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-17-23 Downgrade
Goldman
Buy → Neutral
$25 → $16
Jul-27-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$30 → $21
Jul-27-23 Downgrade
Citigroup
Buy → Neutral
$28 → $22
May-02-23 Downgrade
Barclays
Overweight → Equal Weight
Mar-31-23 Upgrade
Loop Capital
Hold → Buy
$23
Jan-17-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Nov-07-22 Resumed
Jefferies
Buy
$40 → $45
Jun-27-22 Upgrade
Goldman
Neutral → Buy
$31 → $32
Nov-15-21 Downgrade
Goldman
Buy → Neutral
$59 → $57
Nov-12-21 Downgrade
BofA Securities
Buy → Underperform
$63 → $50
Oct-14-21 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$70
Aug-27-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$58 → $57
Jan-11-21 Downgrade
Loop Capital
Buy → Hold
Nov-18-20 Downgrade
Berenberg
Buy → Hold
$42
Feb-04-20 Initiated
BMO Capital Markets
Market Perform
Feb-03-20 Initiated
BMO Capital Markets
Market Perform
Nov-13-19 Initiated
Barclays
Overweight
$34
Oct-01-19 Upgrade
BofA/Merrill
Neutral → Buy
Aug-07-19 Upgrade
Loop Capital
Hold → Buy
$30 → $37
Jul-11-19 Initiated
Goldman
Buy
$33
Show Previous Ratings
Today 08:00AM
Oct-16-24 04:53AM
04:53AM
Oct-09-24 08:03AM
Sep-27-24 04:52AM
08:37AM
Loading…
Sep-24-24 08:37AM
Sep-12-24 06:33AM
01:12AM
Sep-06-24 09:48AM
Aug-28-24 08:00AM
Aug-27-24 08:00AM
Aug-20-24 01:22PM
Aug-08-24 08:25AM
06:00AM
Aug-07-24 06:17AM
06:15AM
Loading…
06:15AM
(Associated Press Finance)
06:01AM
06:00AM
Aug-01-24 04:30PM
Jul-24-24 08:00AM
08:00AM
Jul-22-24 03:19AM
Jul-15-24 09:40AM
Jul-12-24 11:11AM
Jul-05-24 11:50AM
Jul-01-24 04:15PM
08:55AM
Jun-25-24 08:30AM
Jun-07-24 11:30AM
Jun-04-24 08:30AM
08:00AM
Loading…
May-29-24 08:00AM
May-16-24 08:41AM
May-09-24 12:59PM
10:01AM
May-08-24 07:34AM
07:15AM
06:30AM
06:18AM
(Associated Press Finance)
06:11AM
06:00AM
May-02-24 06:16AM
May-01-24 10:01AM
Apr-28-24 07:00AM
Apr-24-24 08:00AM
Apr-19-24 04:44AM
Apr-17-24 03:41AM
Apr-08-24 06:56AM
05:12AM
Mar-28-24 11:30AM
Mar-21-24 08:10AM
Mar-12-24 08:30AM
Mar-06-24 07:30AM
Feb-29-24 08:01AM
Feb-28-24 09:04AM
Feb-27-24 11:19PM
(Thomson Reuters StreetEvents) +15.78%
06:23AM
(Associated Press Finance)
06:15AM
06:12AM
06:10AM
06:00AM
Feb-13-24 08:00AM
Feb-08-24 08:00AM
Jan-30-24 09:00AM
Jan-26-24 08:00AM
Jan-22-24 03:04AM
Jan-19-24 12:14AM
Jan-17-24 08:00AM
Jan-15-24 01:26AM
Jan-12-24 07:19AM
Jan-09-24 08:35AM
Dec-07-23 06:59AM
Nov-10-23 02:10PM
08:08AM
07:34AM
Nov-09-23 07:04AM
06:39AM
06:37AM
(Associated Press Finance)
06:28AM
06:00AM
Oct-31-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 08:30AM
Oct-05-23 04:31PM
Sep-11-23 11:21AM
Sep-05-23 04:05PM
Aug-11-23 08:48AM
Aug-10-23 10:47PM
(Thomson Reuters StreetEvents) -5.54%
09:08AM
06:25AM
(Associated Press Finance)
06:00AM
Aug-09-23 08:32AM
Aug-02-23 12:00PM
Jul-26-23 04:05PM
Jul-20-23 09:00AM
Jul-13-23 04:05PM
Jul-06-23 09:00AM
Jul-01-23 10:30AM
Jun-30-23 10:50PM
Jun-21-23 09:42AM
Jun-05-23 10:26AM
National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Moore Patrick R. Special Advisor Aug 23 '24 Option Exercise 7.25 21,360 154,860 84,542 Aug 27 04:16 PM Moore Patrick R. Special Advisor Aug 23 '24 Sale 10.52 17,661 185,794 66,881 Aug 27 04:16 PM Moore Patrick R. Officer Aug 23 '24 Proposed Sale 10.52 17,661 185,798 Aug 23 12:31 PM PEELER D RANDOLPH Director Aug 13 '24 Buy 10.57 25,000 264,200 207,880 Aug 14 04:27 PM Hepner Virginia A Director Aug 12 '24 Buy 10.37 1,000 10,365 36,635 Aug 14 04:26 PM FAHS L READE Chief Executive Officer May 13 '24 Buy 14.96 20,000 299,200 633,097 May 14 08:01 AM PEELER D RANDOLPH Director May 10 '24 Buy 14.45 34,000 491,198 182,880 May 14 08:00 AM Acharya Ravi SVP, Chief Technology Officer Mar 05 '24 Option Exercise 0.00 2,556 0 16,563 Mar 07 04:19 PM Clark Bill SVP, Chief People Officer Mar 05 '24 Option Exercise 0.00 2,556 0 32,925 Mar 07 04:17 PM Rasmussen Melissa Chief Financial Officer Mar 05 '24 Option Exercise 0.00 1,279 0 21,689 Mar 07 04:16 PM Brandman Jared SVP, GC and Secretary Mar 05 '24 Option Exercise 0.00 2,556 0 36,030 Mar 07 04:15 PM Moore Patrick R. Chief Operating Officer Mar 05 '24 Option Exercise 0.00 5,111 0 64,708 Mar 07 04:13 PM FAHS L READE Chief Executive Officer Mar 05 '24 Option Exercise 0.00 20,078 0 619,089 Mar 07 04:11 PM Rasmussen Melissa Chief Financial Officer Nov 18 '23 Option Exercise 0.00 2,745 0 15,301 Nov 21 04:33 PM Moore Patrick R. Chief Operating Officer Nov 18 '23 Option Exercise 0.00 2,745 0 49,619 Nov 21 04:31 PM
Index RUT
P/E 90.81
EPS (ttm) 0.34
Insider Own 0.67%
Shs Outstand 49.19M
Perf Week -5.29%
Market Cap 1.50B
Forward P/E 39.75
EPS next Y 0.77
Insider Trans 0.40%
Shs Float 48.86M
Perf Month 0.20%
Income 16.61M
PEG 3.03
EPS next Q 0.18
Inst Own 92.13%
Short Float 10.35%
Perf Quarter -26.56%
Sales 332.94M
P/S 4.49
EPS this Y -28.04%
Inst Trans -2.67%
Short Ratio 6.22
Perf Half Y -36.87%
Book/sh 8.32
P/B 3.66
EPS next Y 5.28%
ROA 3.49%
Short Interest 5.06M
Perf Year -27.09%
Cash/sh 4.78
P/C 6.36
EPS next 5Y 30.00%
ROE 4.36%
52W Range 26.66 - 52.68
Perf YTD -2.53%
Dividend Est. -
P/FCF 110.43
EPS past 5Y 31.51%
ROI 3.77%
52W High -42.26%
Beta 0.58
Dividend TTM -
Quick Ratio 5.21
Sales past 5Y 21.55%
Gross Margin 79.24%
52W Low 14.12%
ATR (14) 1.54
Dividend Ex-Date -
Current Ratio 5.80
EPS Y/Y TTM -34.15%
Oper. Margin 7.90%
RSI (14) 40.47
Volatility 3.60% 4.70%
Employees 1115
Debt/Eq 0.09
Sales Y/Y TTM 8.83%
Profit Margin 4.99%
Recom 2.00
Target Price 48.64
Option/Short Yes / Yes
LT Debt/Eq 0.08
EPS Q/Q 20.90%
Payout 0.00%
Rel Volume 0.54
Prev Close 30.69
Sales Surprise 3.98%
EPS Surprise 63.25%
Sales Q/Q 7.26%
Earnings Aug 07 AMC
Avg Volume 813.90K
Price 30.42
SMA20 -7.87%
SMA50 -7.52%
SMA200 -19.26%
Trades
Volume 439,999
Change -0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-15-24 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$50 → $37
Jun-11-24 Upgrade
BTIG Research
Neutral → Buy
$46
Mar-11-24 Upgrade
Stifel
Hold → Buy
$30 → $50
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Nov-07-22 Upgrade
Sidoti
Neutral → Buy
Oct-14-22 Resumed
Stephens
Overweight
$91
Oct-13-22 Initiated
Mizuho
Buy
$85
Apr-08-22 Initiated
Needham
Buy
$87
Mar-28-22 Upgrade
The Benchmark Company
Hold → Buy
$97
Mar-18-22 Upgrade
BTIG Research
Neutral → Buy
$98
Jul-09-21 Initiated
Oppenheimer
Perform
$150
Jan-19-21 Downgrade
The Benchmark Company
Buy → Hold
Show Previous Ratings
Today 07:00AM
Oct-07-24 09:55AM
Sep-27-24 09:55AM
Sep-23-24 07:00AM
Sep-17-24 08:00AM
12:00PM
Loading…
Sep-16-24 12:00PM
Sep-06-24 01:01PM
Aug-13-24 10:48AM
Aug-12-24 09:15AM
Aug-07-24 11:53PM
08:00PM
05:20PM
04:22PM
(Associated Press Finance)
04:01PM
Jul-31-24 07:00AM
07:00AM
Loading…
Jul-30-24 07:00AM
Jun-27-24 01:25PM
(Investor's Business Daily)
04:01AM
Jun-05-24 07:00AM
May-13-24 11:06AM
May-08-24 11:06AM
10:17AM
07:59AM
03:43AM
May-07-24 11:54PM
07:30PM
05:58PM
05:26PM
(Associated Press Finance)
04:03PM
04:01PM
09:16AM
Loading…
May-06-24 09:16AM
May-01-24 07:00AM
Apr-29-24 07:00AM
Apr-25-24 03:43PM
(Investor's Business Daily)
Apr-05-24 09:15AM
Apr-04-24 04:26PM
(Investor's Business Daily) +16.48%
03:54PM
07:00AM
Apr-02-24 07:00AM
Mar-26-24 11:45AM
Mar-20-24 04:22AM
Mar-18-24 07:00AM
Mar-12-24 10:30AM
07:00AM
Mar-06-24 07:00AM
Feb-28-24 10:58AM
Feb-27-24 02:00PM
Feb-26-24 05:30PM
04:39PM
(Associated Press Finance)
04:34PM
04:01PM
Feb-19-24 07:00AM
Jan-27-24 01:03PM
Jan-23-24 07:00AM
Jan-12-24 06:49PM
Jan-08-24 07:00AM
Dec-17-23 12:35PM
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
Nov-02-23 05:50PM
09:23AM
(Thomson Reuters StreetEvents)
Nov-01-23 06:30PM
05:56PM
04:17PM
(Associated Press Finance)
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
Oct-10-23 10:51AM
Sep-19-23 11:51AM
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Butcher Arthur C Director Aug 12 '24 Buy 37.99 1,315 49,957 4,208 Aug 19 05:31 PM BROADWOOD PARTNERS, L.P. 10% Owner May 09 '24 Buy 42.56 1 43 10,768,431 May 13 06:00 PM WEISNER AIMEE S Director Mar 14 '24 Buy 38.11 1,750 66,692 10,864 Mar 14 05:23 PM Williams Patrick F. Chief Financial Officer Mar 07 '24 Option Exercise 0.00 2,614 0 45,475 Mar 11 06:06 AM BROADWOOD PARTNERS, L.P. 10% Owner Jan 08 '24 Buy 27.11 4,042 109,570 10,768,430 Jan 10 05:44 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 05 '24 Buy 28.48 156,734 4,463,231 10,764,388 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 04 '24 Buy 28.91 63,246 1,828,183 10,607,654 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 03 '24 Buy 28.93 6,573 190,144 10,544,408 Jan 05 07:07 PM Zhou Lilian Yansheng Director Dec 06 '23 Buy 30.74 850 26,129 2,327 Dec 06 04:11 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 30 '23 Buy 31.42 177,707 5,583,678 10,537,835 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 29 '23 Buy 31.39 160,300 5,031,358 10,360,128 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 28 '23 Buy 31.85 96,984 3,088,794 10,199,828 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 10 '23 Buy 32.73 34,320 1,123,383 10,102,337 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 13 '23 Buy 33.04 507 16,749 10,102,844 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 08 '23 Buy 33.71 139,409 4,699,073 9,928,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 09 '23 Buy 33.09 140,000 4,632,581 10,068,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 07 '23 Buy 34.03 9,731 331,127 9,788,608 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 06 '23 Buy 34.16 164,607 5,623,518 9,778,877 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 02 '23 Buy 35.79 144,027 5,155,243 9,613,750 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 03 '23 Buy 36.06 520 18,753 9,614,270 Nov 06 07:01 PM
Index -
P/E -
EPS (ttm) -1.30
Insider Own 88.98%
Shs Outstand 350.91M
Perf Week -1.88%
Market Cap 7.16B
Forward P/E 23.87
EPS next Y 0.85
Insider Trans 0.01%
Shs Float 38.79M
Perf Month 4.47%
Income -456.00M
PEG -
EPS next Q 0.16
Inst Own 11.55%
Short Float 3.72%
Perf Quarter 25.85%
Sales 4.50B
P/S 1.59
EPS this Y -17.37%
Inst Trans 6.65%
Short Ratio 1.73
Perf Half Y 37.04%
Book/sh 18.49
P/B 1.10
EPS next Y 41.32%
ROA -3.71%
Short Interest 1.44M
Perf Year 20.34%
Cash/sh 0.86
P/C 23.71
EPS next 5Y 15.01%
ROE -6.77%
52W Range 13.16 - 21.69
Perf YTD 19.28%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -4.11%
52W High -6.18%
Beta 0.48
Dividend TTM -
Quick Ratio 1.01
Sales past 5Y 2.77%
Gross Margin 54.73%
52W Low 54.64%
ATR (14) 0.66
Dividend Ex-Date -
Current Ratio 1.65
EPS Y/Y TTM -222.37%
Oper. Margin 4.27%
RSI (14) 63.27
Volatility 2.70% 2.62%
Employees 13300
Debt/Eq 0.71
Sales Y/Y TTM 15.14%
Profit Margin -10.14%
Recom 2.06
Target Price 20.83
Option/Short Yes / Yes
LT Debt/Eq 0.71
EPS Q/Q -370.10%
Payout -
Rel Volume 0.91
Prev Close 20.68
Sales Surprise 3.86%
EPS Surprise 1.17%
Sales Q/Q 17.49%
Earnings Oct 30 BMO
Avg Volume 832.04K
Price 20.35
SMA20 3.83%
SMA50 13.76%
SMA200 27.16%
Trades
Volume 754,781
Change -1.60%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-15-24 Upgrade
Evercore ISI
In-line → Outperform
$19 → $25
Jul-10-24 Initiated
Raymond James
Outperform
$19
May-06-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$16 → $18
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$19 → $17
Dec-12-23 Initiated
Stifel
Hold
$16
Oct-03-23 Resumed
Evercore ISI
Outperform
$20
May-30-23 Resumed
Morgan Stanley
Equal-Weight
$20
Mar-09-23 Initiated
Needham
Hold
Dec-21-22 Initiated
Barclays
Equal Weight
$17
Sep-12-22 Initiated
H.C. Wainwright
Buy
$21
Jul-26-22 Initiated
RBC Capital Mkts
Outperform
$22
Jun-24-22 Initiated
Evercore ISI
Outperform
$21
Jun-06-22 Initiated
Citigroup
Buy
May-31-22 Initiated
Wells Fargo
Overweight
$23
May-31-22 Initiated
Morgan Stanley
Equal-Weight
$22
May-31-22 Initiated
JP Morgan
Neutral
$20
May-31-22 Initiated
Jefferies
Buy
$25
May-31-22 Initiated
Guggenheim
Buy
$24
May-31-22 Initiated
Goldman
Neutral
$22
May-31-22 Initiated
Deutsche Bank
Hold
$19
Show Previous Ratings
Oct-14-24 11:38AM
10:57AM
07:00AM
Oct-09-24 08:00AM
Oct-02-24 08:40AM
07:00AM
Loading…
Oct-01-24 07:00AM
Sep-18-24 11:01AM
(Morningstar Research) +7.76%
Sep-16-24 06:35PM
(Morningstar Research) +14.47%
12:26PM
09:52AM
(The Wall Street Journal)
07:22AM
Aug-07-24 11:37PM
Aug-05-24 06:45PM
(Morningstar Research) -5.70%
Aug-01-24 10:41AM
Jul-31-24 03:55PM
12:08PM
Loading…
12:08PM
07:00AM
Jul-30-24 06:33PM
Jul-25-24 06:33PM
Jul-24-24 06:24PM
(Morningstar Research) -5.05%
Jul-17-24 06:53PM
Jul-11-24 12:05PM
Jul-08-24 07:00AM
Jun-17-24 07:00AM
Jun-10-24 07:00AM
Jun-03-24 07:00AM
May-29-24 04:30PM
May-28-24 09:00AM
06:59AM
May-03-24 04:06PM
03:35PM
Loading…
03:35PM
May-02-24 03:03PM
May-01-24 11:54AM
08:33AM
06:58AM
Apr-29-24 07:00AM
Apr-25-24 08:30AM
Apr-24-24 10:01AM
Apr-18-24 07:00AM
Apr-15-24 12:00PM
Mar-27-24 07:00AM
Mar-25-24 12:00PM
Mar-20-24 12:20PM
Mar-19-24 08:50AM
Mar-08-24 10:10AM
Feb-28-24 08:00AM
Feb-23-24 03:05PM
Feb-22-24 11:30AM
Feb-21-24 10:35PM
(Thomson Reuters StreetEvents) +13.78%
07:04PM
09:30AM
07:36AM
07:31AM
07:00AM
06:58AM
Feb-15-24 09:15AM
Feb-14-24 12:10PM
10:00AM
Feb-05-24 12:00PM
Jan-17-24 06:54PM
Jan-09-24 12:41PM
Jan-08-24 06:59AM
Jan-03-24 09:00AM
Nov-28-23 01:25PM
(The Wall Street Journal)
Nov-15-23 06:59AM
Nov-03-23 11:01AM
Nov-01-23 03:19PM
09:21AM
06:58AM
Oct-26-23 06:59AM
Oct-16-23 12:00PM
Oct-04-23 06:59AM
Sep-29-23 10:15AM
10:00AM
Sep-26-23 06:59AM
Sep-20-23 06:59AM
Sep-19-23 08:32AM
Sep-18-23 11:56AM
Sep-14-23 05:25PM
Sep-12-23 06:59AM
Sep-11-23 08:00AM
07:07AM
Sep-06-23 05:58PM
06:59AM
Aug-29-23 07:00AM
Aug-24-23 07:00AM
Aug-02-23 05:25PM
06:59AM
Aug-01-23 08:00AM
Jul-11-23 07:00AM
Jul-06-23 07:00AM
Jul-03-23 10:12AM
Jun-30-23 06:48PM
08:30AM
08:28AM
(The Wall Street Journal)
08:00AM
Jun-14-23 09:43AM
Jun-12-23 07:00AM
Jun-08-23 07:00AM
Jun-06-23 07:00AM
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SAUNDERS BRENT L CEO and Chairman of the Board Aug 05 '24 Buy 15.66 32,250 505,067 595,169 Aug 07 05:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite